Medicare launches $50 Wegovy pilot with strict eligibility

Medicare launches $50 Wegovy pilot with strict eligibility

The Centers for Medicare & Medicaid Services said that Medicare launched a $50-per-month Wegovy pilot on July 1, 2026, limited to beneficiaries who meet strict BMI and health-condition criteria and are enrolled in an eligible Part D plan. The 18-month demonstration provides coverage for GLP-1 obesity drugs at a $50 monthly copay for eligible seniors, with eligibility based on body-mass-index thresholds and certain health conditions, and is scheduled to run through the end of 2027, as reported by CBS News, CNBC, ABC News and AP News.

Acteurs

Medicare Centers for Medicare & Medicaid Services Eli Lilly Novo Nordisk Juliette Cubanski KFF

Lieux

Aucun enregistrement

Articles

29 juillet 2026
1 au total
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.

24/7 Wall St. • 29 juil. 12h03

Starting July 1, 2026, Medicare will offer a $50 copay for certain GLP-1 drugs, including Wegovy, but only beneficiaries who meet specific BMI and health-condition requirements and are enrolled in an eligible Part D plan can access the benefit.

Crédibilité 72% Manip. 8% Centre
1 juillet 2026
2 au total
What to know about Medicare's $50 GLP-1 program
What to know about Medicare's $50 GLP-1 program

AP News • 01 juil. 11h09

A new Medicare program will provide selected GLP-1 weight-loss medications to qualifying beneficiaries for $50 a month through 2027, with eligibility based on BMI and health conditions.

Crédibilité 78% Manip. 8% Centre
Eligible seniors can get GLP-1s for $50 a month for weight loss alone
Eligible seniors can get GLP-1s for $50 a month for weight loss alone

ABC News - Breaking News, Latest News and Videos • 01 juil. 09h14

A new federal pilot program will allow eligible Medicare beneficiaries to obtain GLP-1 medications for obesity at a $50 co-pay per month, beginning in July and running through the end of 2027.

Crédibilité 72% Manip. 8% Centre
30 juin 2026
1 au total
Medicare obesity drug GLP-1 coverage starting July 1
Medicare obesity drug GLP-1 coverage starting July 1

CNBC • 30 juin 09h00

A new Medicare demonstration program will pay for GLP-1 obesity medications for eligible seniors at a $50 monthly copayment, but the coverage is set to expire in 2027.

Crédibilité 78% Manip. 9% Centre
29 juin 2026
1 au total
Medicare to cover GLP-1 drugs for weight loss starting July 1. Here's what to know.
Medicare to cover GLP-1 drugs for weight loss starting July 1. Here's what to know.

CBS News • 29 juin 19h39

Starting July 1, Medicare will offer an 18-month pilot that pays for certain GLP-1 medications prescribed for obesity, requiring a $50 monthly copay for eligible beneficiaries.

Crédibilité 73% Manip. 12% Centre